Inflammatory bowel disease affecting the colon and rectum continuously. Driven by gut dysbiosis, leaky gut, and dysregulated immune response. Anti-inflammatory diet (specific carbohydrate diet, IBD-AID), curcumin, omega-3, and Saccharomyces boulardii support remission.
Last updated:
Ulcerative Colitis (UC) is a chronic inflammatory bowel disease that causes continuous inflammation and ulcers in the innermost lining (mucosa) of the colon and rectum. Unlike Crohn's disease, UC affects ONLY the colon, never skipping segments, never extending beyond the mucosa, and inflammation always starts at the rectum and extends proximally without interruption.
UC is driven by a complex interplay: genetic susceptibility (over 200 genes identified), gut microbiome dysbiosis, intestinal barrier dysfunction (leaky gut), and dysregulated immune response. The bacterial-immune dialogue at the colonic mucosa goes awry, the immune system attacks the colon as if it were a foreign invader, while the gut microbiome composition shifts toward inflammatory species.
UC typically follows a relapsing-remitting course: periods of active inflammation (flares) alternate with remission. Nutrition, stress, sleep, and microbiome health profoundly influence both flare frequency and severity. While there's no "cure" short of colectomy, sustained deep remission is achievable with combined medical + lifestyle/nutritional approach.
Inflammation limited to rectum (proctitis) or rectum + sigmoid (proctosigmoiditis). Most common at diagnosis. Often responsive to topical (rectal) therapies. Lower colon cancer risk than extensive disease.
Inflammation extends past splenic flexure, often affecting entire colon. Higher risk of complications (toxic megacolon, perforation, dysplasia, colorectal cancer). More aggressive therapy required.
Symptoms vary by severity (mild, moderate, severe, fulminant) and extent. Bloody diarrhea is the hallmark. Extra-intestinal manifestations also occur in ~30% of patients.
Frequent loose stools with visible blood and/or mucus. Number of bowel movements correlates with severity, <4/day mild; 4-6 moderate; >6 with systemic symptoms severe. Often nocturnal stools wake patient.
Tenesmus = painful, ineffective urge to defecate. Sudden, urgent need to use bathroom (sometimes can't make it). Profoundly impacts quality of life; common to confine activities near bathroom access.
Especially in left lower quadrant (sigmoid colon). Cramps often precede or accompany bowel movements. Relieved (transiently) by defecation.
From malabsorption, inflammation, and reduced intake during flares. Significant weight loss indicates active disease or severe flare.
Peripheral arthritis (large joints, parallels disease activity) OR axial spondyloarthritis (spine, independent of disease activity). Affects ~20% of UC patients.
Painful red eye, vision changes, light sensitivity. Requires urgent ophthalmology evaluation, uveitis can damage vision permanently.
Erythema nodosum (painful red shins) and pyoderma gangrenosum (ulcerating skin lesions), both reflect systemic inflammation tied to UC activity.
Liver/bile duct inflammation, occurs in ~5% of UC patients. Causes elevated alkaline phosphatase, fatigue, pruritus. Increases cancer risk significantly.
Direct visualization of continuous mucosal inflammation starting at the rectum. Biopsies show characteristic chronic inflammation, crypt abscesses, distorted crypt architecture. Distinguishes UC from Crohn's and other colitis types.
Non-invasive marker of gut inflammation. Helps distinguish IBD from IBS; monitors flare vs remission. <50 ยตg/g normal; >250 suggests active inflammation.
Anemia (chronic blood loss), elevated CRP/ESR (systemic inflammation), low albumin (severe disease). Help assess severity and chronicity.
Anti-inflammatory diet (SCD, IBD-AID, Mediterranean) + microbiome restoration + curcumin + omega-3 + stress management
The "right" UC diet varies by individual and disease phase. During flares: gentle, easy to digest. During remission: focus on anti-inflammatory, microbiome-supportive foods.
Salmon, sardines, mackerel. EPA/DHA reduce inflammation. 3x/week minimum during stable phases.
Steamed or roasted carrots, zucchini, squash. During flares: cooked, peeled, low-fiber. During remission: gradually expand variety.
Anti-inflammatory liquids and herbs. Bone broth supports mucosal healing. Green tea (decaf during flares) is anti-inflammatory.
Olive oil, avocado, eggs, fish, well-cooked chicken. Maintain nutrition during flares with easy-to-digest options.
Feed dysbiotic bacteria, promote inflammation. Carrageenan, emulsifiers, artificial sweeteners disrupt gut barrier.
~70% of IBD patients have lactose intolerance during flares. Casein may also trigger inflammation. Test elimination.
All can trigger flares or worsen symptoms during flares. Alcohol particularly worsens prognosis long-term.
Raw cabbage, broccoli, kale, popcorn, seeds, nuts can mechanically irritate inflamed mucosa during flares. Reintroduce gradually in remission.
These supplements have RCT-level evidence in UC. Use as adjuncts to medical therapy, with gastroenterologist awareness.
| Supplement | Mechanism & Evidence | Suggested Dose | Timing | Notes |
|---|---|---|---|---|
| Curcumin (Turmeric Extract) | NF-ฮบB inhibition, broad anti-inflammatory. Holt & Ravindra studies: 50% reduction in UC relapse as add-on to mesalamine maintenance. | 1-3g/day bioavailable form | With meals, divided | Meriva, Theracurmin, BCM-95 forms best absorbed. Avoid with anticoagulants. |
| Boswellia Serrata | Inhibits 5-lipoxygenase, reducing leukotriene-mediated inflammation. Some trials show efficacy comparable to mesalamine in mild-moderate UC. | 350mg 3x/day | With meals | Standardized to โฅ65% boswellic acids. AKBA-enriched products may be more potent. |
| Omega-3 EPA/DHA | Anti-inflammatory eicosanoid production. Mixed clinical evidence; modest benefit in maintenance. Best results with high doses. | 2-4g combined EPA+DHA/day | With fat meal | IFOS-certified triglyceride form best absorbed. |
| Vitamin D3 | Strong inverse association between vitamin D and UC severity. Repletion reduces relapse rates. Target 50-70 ng/mL. | 4,000-10,000 IU/day to reach target | With fat meal | Test 25(OH)D every 3-6 months. Always pair with K2. |
| VSL#3 / Visbiome (High-Strength Probiotic) | Strongest probiotic evidence in UC. Multiple RCTs support efficacy in inducing and maintaining remission, especially in pouchitis. | 900 billion CFU/day during active disease; 450 billion maintenance | With meals | Refrigerated formulations preferred for viability. |
| S. boulardii | Specifically helpful during antibiotic courses and to prevent/treat C. diff (common complication in IBD). | 500mg 2x/day | With meals | Safe with immunosuppression but discuss with gastroenterologist. |
| Iron (IV preferred in active UC) | Oral iron worsens UC inflammation in many patients. IV iron (iron sucrose, ferric carboxymaltose) repletes deficiency without GI side effects. | Per gastroenterologist | โ | IV iron 1-3 doses typically repletes deficit. Avoid oral iron during flares. |
| L-Glutamine + Butyrate | Primary fuel for colonocytes (especially butyrate). Butyrate enemas have specific UC evidence for distal disease. | Glutamine 5-10g/day oral; butyrate 4g/enema | Between meals; enemas at bedtime | Butyrate enemas require compounding pharmacy. Distinct from oral butyrate supplements. |
UC is a lifelong condition, but the combination of medical therapy + targeted nutrition + microbiome support + lifestyle can achieve and maintain deep remission for many patients. The earlier and more comprehensive the approach, the better the long-term outcomes.